Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer

Triple-negative breast cancer (TNBC), which is largely synonymous with the basal-like molecular subtype, is the 5th leading cause of cancer deaths for women in the United States. The overall prognosis for TNBC patients remains poor given that few treatment options exist; including targeted therapies...

Full description

Bibliographic Details
Main Authors: Beste Turanli, Kubra Karagoz, Gholamreza Bidkhori, Raghu Sinha, Michael L. Gatza, Mathias Uhlen, Adil Mardinoglu, Kazim Yalcin Arga
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Genetics
Subjects:
breast cancer
drug repositioning
non-cancer therapeutics
repurposing
basal subtype
personalized metabolic models
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2019.00420/full

Internet

https://www.frontiersin.org/article/10.3389/fgene.2019.00420/full

Similar Items